The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Open accessPublished version of a preprint
Abstract
Recent population studies provide clues that the use of metformin may be associated with reduced incidence and improved prognosis of certain cancers. This drug is widely used in the treatment of type 2 diabetes, where it is often referred to as an "insulin sensitizer" because it not only lowers blood glucose but also reduces the hyperinsulinemia associated with insulin resistance. As insulin and insulin-like growth factors stimulate proliferation of many normal and transformed cell types, agents that facilitate signaling through these receptors would be expected to enhance proliferation. We show here that metformin acts as a growth inhibitor rather than an insulin sensitizer for epithelial cells. Breast cancer cells can be protected against metformin-induced growth inhibition by small interfering RNA against AMP kinase. This shows that AMP kinase pathway activation by metformin, recently shown to be necessary for metformin inhibition of gluconeogenesis in hepatocytes, is also involved in metformin-induced growth inhibition of epithelial cells. The growth inhibition was associated with decreased mammalian target of rapamycin and S6 kinase activation and a general decrease in mRNA translation. These results provide evidence for a mechanism that may contribute to the antineoplastic effects of metformin suggested by recent population studies and justify further work to explore potential roles for activators of AMP kinase in cancer prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some of these mechanisms may be through inhibition of cell growth [148], IGF-1 signaling [149], inhibition of the mTOR pathway [150], reduction of human epidermal growth factor receptor type 2 (HER-2) expression (a major driver of proliferation in breast cancer) [151], inhibition of angiogenesis and inflammation [152], induction of apoptosis and protein 53 (p53) activation [153], cell cycle arrest”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [150]
In the citing paper
“and interference with glucose(266), protein(267, 268), and lipid(269) metabolism of the neoplastic cells.”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [268]
In the citing paper
“In laboratory studies, metformin has been shown to inhibit cell proliferation, reduce colony formation, and cause partial cell cycle arrest in cancer cell lines (81–83).”
From Diabetes and Cancer (2010) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I. P. M., Avizienyte, E., Roth, S., Loukola, A., Bignell, G. R., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,680
Insulin-like growth factors and neoplasia
Pollak, M., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1387 · Cited by 1,477
Self-citationVery high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N. M., Manning, B. D., Lopez, L. V., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,107
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 978
Cited by
Sorted by citations
Items 201–300 of 1,000
Amin, S., Lux, A. L., & O'Callaghan, F. J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13780 · Cited by 128
Corominas-Faja, B., Quirantes‐Piné, R., Oliveras‐Ferraros, C., Vázquez‐Martín, A., Cufí, S., Martı́n-Castillo, B., Micol, V., Joven, J., Segura‐Carretero, A., & Menéndez, J. A. (2012) · Aging · doi:10.18632/aging.100472 · Cited by 121
The metabolic modulator PGC-1α in cancer.
Bost, F., & Kaminski, L. (2019) · Europe PMC (PubMed Central) · Cited by 119
The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis
Parsyan, A. E., Shahbazian, D., Martineau, Y., Petroulakis, E., Alain, T., Larsson, O. S., Mathonnet, G., Tettweiler, G., Hellen, C. U. T., Pestova, T. V., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909773106 · Cited by 118
Self-citationMetformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy
Dowling, R. J. O., Lam, S. H. L., Bassi, C., Mouaaz, S., Aman, A. M., Kiyota, T., Al‐awar, R., Goodwin, P. J., & Stambolic, V. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.006 · Cited by 118
Self-citationDowling, R. J., Niraula, S., Chang, M. C., Done, S. J., Ennis, M., McCready, D. R., Leong, W. L., Escallon, J. M., Reedijk, M., Goodwin, P. J., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0540-0 · Cited by 117
Self-citationMolecular Mechanisms of Metformin for Diabetes and Cancer Treatment
Li, M., Li, X., Zhang, H., & Lü, Y. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01039 · Cited by 125
Pollak, M. (2014) · Nature Medicine · doi:10.1038/nm.3596 · Cited by 115
Self-citationEnergy disruptors: rising stars in anticancer therapy?
Bost, F., Poullot, A. G., Tanti, J., & Clavel, S. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.46 · Cited by 119
Insights into the Link Between Obesity and Cancer
Ackerman, S. E., Blackburn, O. A., Marchildon, F., & Cohen, P. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0263-x · Cited by 121
Haugrud, A. B., Zhuang, Y., Coppock, J. D., & Miskimins, W. K. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3128-y · Cited by 115
Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells
Goldberg, A. A., Beach, A., Davies, G. F., Harkness, T. A. A., LeBlanc, A. C., & Titorenko, V. I. (2011) · Oncotarget · doi:10.18632/oncotarget.338 · Cited by 112
Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle
Hadad, S. M., Hardie, D. G., Appleyard, V., & Thompson, A. M. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1144-8 · Cited by 113
Chiang, E. I., Tsai, S.-Y., Kuo, Y., Pai, M., Chiu, H., Rodriguez, R. L., & Tang, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099631 · Cited by 118
A Gene Signature-Based Approach Identifies mTOR as a Regulator of p73
Rosenbluth, J. M., Mays, D. J., Pino, M. F., Tang, L. J., & Pietenpol, J. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00305-08 · Cited by 114
Janjetović, K., Vucicevic, L. M., Misirkic-Marjanovic, M., Vilimanovich, U., Tovilović-Kovačević, G., Zogovic, N. S., Nikolić, Z., Jovanović, S., Bumbasirevic, V. Z., Trajković, V., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.11.005 · Cited by 115
Association Between Metformin Therapy and Mortality After Breast Cancer
Lega, I. C., Austin, P. C., Gruneir, A., Goodwin, P. J., Rochon, P. A., & Lipscombe, L. L. (2013) · Diabetes Care · doi:10.2337/dc12-2535 · Cited by 111
The management of gestational diabetes
Cheung, W. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3405 · Cited by 111
Gou, S., Cui, P., Li, X., Shi, P., Liu, T., & Wang, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063969 · Cited by 109
Zhuang, Y., & Miskimins, W. K. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0343 · Cited by 113
Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
Monami, M., Colombi, C., Balzi, D., Dicembrini, I., Giannini, S., Melani, C., Vitale, V., Romano, D., Barchielli, A., Marchionni, N., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1287 · Cited by 110
Sivalingam, V. N., Myers, J., Nicholas, S., Balen, A. H., & Crosbie, E. J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu037 · Cited by 113
Cancer: fundamentals behind pH targeting and the double-edged approach
Koltai, T. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s115438 · Cited by 110
Targeting Lipid Metabolism in Liver Cancer
Alannan, M., Fayyad‐Kazan, H., Trézéguet, V., & Merched, A. J. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00477 · Cited by 110
Sunayama, J., Sato, A., Matsuda, K., Tachibana, K., Watanabe, E., Seino, S., Suzuki, K., Narita, Y., Shibui, S., Sakurada, K., et al. (2011) · Stem Cells · doi:10.1002/stem.696 · Cited by 109
for the DIGAMI 2 Investigators, Mellbin, L., Malmberg, K., Norhammar, A., Wedel, H., & Rydén, L. (2011) · Diabetologia · doi:10.1007/s00125-011-2084-x · Cited by 107
Targeting LKB1 signaling in cancer
Korsse, S. E., Peppelenbosch, M. P., & van Veelen, W. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.12.006 · Cited by 107
Chen, D., Pamu, S., Cui, Q. C., Chan, T. H., & Dou, Q. P. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.002 · Cited by 106
Wahdan-Alaswad, R. S., Cochrane, D. R., Spoelstra, N. S., Howe, E. N., Edgerton, S. M., Anderson, S. M., Thor, A. D., & Richer, J. K. (2014) · Hormones and Cancer · doi:10.1007/s12672-014-0188-8 · Cited by 104
Lu, C., Chiang, J., Tsai, F., Hsu, Y., Juan, Y., Yang, J., & Chiu, H. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4704 · Cited by 105
Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer
Colquhoun, A., Venier, N. A., Vandersluis, A. D., Besla, R., Sugar, L., Kiss, A., Fleshner, N. E., Pollak, M., Klotz, L. H., & Venkateswaran, V. K. (2012) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2012.16 · Cited by 103
Self-citationLaskov, I., Drudi, L. M., Beauchamp, M.-C., Yasmeen, A., Ferenczy, A. S., Pollak, M., & Gotlieb, W. H. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.06.014 · Cited by 103
Self-citationObesity, metabolism and the microenvironment: Links to cancer
Makowski, L., Sundaram, S., & Johnson, A. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.119606 · Cited by 106
Lin, C., Yeh, H.-H., Huang, W.-L., Yan, J.-J., Lai, W., Su, W., Chen, H. H. W., & Su, W. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0244oc · Cited by 104
Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy
Koritzinsky, M. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.06.003 · Cited by 103
MYME investigators, Nanni, O., Amadori, D., DeCensi, A., Rocca, A., Freschi, A., Bologna, A., Gianni, L., Rosetti, F., Amaducci, L., et al. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-05070-2 · Cited by 105
Marycz, K., Tomaszewski, K. A., Kornicka, K., Henry, B. M., Wroński, S., Tarasiuk, J., & Marędziak, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9785890 · Cited by 102
Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease
Shillingford, J. M., Leamon, C. P., Vlahov, I. R., & Weimbs, T. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040367 · Cited by 105
Association of Obesity-Related Metabolic Disruptions With Cancer Risk and Outcome
Lohmann, A. E., Goodwin, P. J., Chlebowski, R. T., Pan, K., Stambolic, V., & Dowling, R. J. O. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.6187 · Cited by 101
Self-citationAMP-Activated Kinase Restricts Rift Valley Fever Virus Infection by Inhibiting Fatty Acid Synthesis
Moser, T. S., Schieffer, D., & Cherry, S. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002661 · Cited by 102
Role of AMP‐Activated Protein Kinase in Cancer Therapy
Rehman, G., Shehzad, A., Khan, A. L., & Hamayun, M. (2014) · Archiv der Pharmazie · doi:10.1002/ardp.201300402 · Cited by 107
Insulin, insulin-like growth factors and neoplasia
Pollak, M. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.08.004 · Cited by 100
Self-citationVázquez‐Martín, A., Vellón, L., Quirós, P. M., Cufí, S., de Galarreta, E. R., Oliveras‐Ferraros, C., Martín, Á. G., Martı́n-Castillo, B., López-Otı́n, C., & Menéndez, J. A. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19450 · Cited by 98
Metformin and Prostate Cancer: a New Role for an Old Drug
Whitburn, J., Edwards, C. M., & Sooriakumaran, P. (2017) · Current Urology Reports · doi:10.1007/s11934-017-0693-8 · Cited by 98
The Insulin Receptor: A New Target for Cancer Therapy
Malaguarnera, R., & Belfiore, A. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00093 · Cited by 98
The Insulin Receptor/Insulin-Like Growth Factor Receptor Family as a Therapeutic Target in Oncology
Pollak, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0998 · Cited by 97
Self-citationSilymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer
Fallah, M., Davoodvandi, A., Nikmanzar, S., Aghili, S., Mirazimi, S. M. A., Aschner, M., Rashidian, A., Hamblin, M. R., Chamanara, M., Naghsh, N., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112024 · Cited by 101
Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening
Woo, H. G., Park, E. S., Lee, J., Lee, Y.-H., Ishikawa, T., Kim, Y. J., & Thorgeirsson, S. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0164 · Cited by 96
Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy
Phoenix, K. N., Vumbaca, F., Fox, M. M., Evans, R., & Claffey, K. P. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0647-z · Cited by 94
Eleostearic Acid Inhibits Breast Cancer Proliferation by Means of an Oxidation-Dependent Mechanism
Grossmann, M. E., Mizuno, N. K., Dammen, M. L., Schuster, T. F., Ray, A., & Cleary, M. P. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0088 · Cited by 97
Daurio, N. A., Tuttle, S. W., Worth, A. J., Song, E. Y., Davis, J. M., Snyder, N. W., Blair, I. A., & Koumenis, C. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2197 · Cited by 100
Bai, L., Yi, W., Sun, T., Tian, Y., Zhang, P., Si, J., Hou, X., & Hou, J. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01084g · Cited by 95
RetractedA prospective study of type 2 diabetes, metformin use, and risk of breast cancer
Park, Y., Bookwalter, D. B., O’Brien, K. M., Jackson, C. L., Weinberg, C. R., & Sandler, D. P. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2020.12.008 · Cited by 99
Hadad, S. M., Coates, P. J., Jordan, L. B., Dowling, R. J. O., Chang, M. C., Done, S. J., Purdie, C. A., Goodwin, P. J., Stambolic, V., Moulder-Thompson, S. L., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3307-5 · Cited by 97
Self-citationThe prince and the pauper. A tale of anticancer targeted agents
Dueñas‐González, A., García‐López, P., Herrera, L. A., Medina‐Franco, J. L., González‐Fierro, A., & Candelaria, M. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-82 · Cited by 94
Sun, S., Gong, F., Liu, P., & Miao, Q. (2018) · Gene · doi:10.1016/j.gene.2018.04.045 · Cited by 94
The complexities of obesity and diabetes with the development and progression of pancreatic cancer
Bao, B., Wang, Z., Li, Y., Kong, D., Ali, S. S., Banerjee, S., Ahmad, A., & Sarkar, F. H. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.11.003 · Cited by 94
Role of ketogenic metabolic therapy in malignant glioma: A systematic review
Winter, S. F., Loebel, F., & Dietrich, J. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.02.016 · Cited by 95
Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy
Lee, C., Jung, M., Jung, I., Heo, S. J., Jeong, Y. H., An, J. Y., Kim, H., Cheong, J., Hyung, W. J., Noh, S. H., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001086 · Cited by 92
Targeting the Hippo Pathway for Breast Cancer Therapy
Wu, L., & Yang, X. (2018) · Cancers · doi:10.3390/cancers10110422 · Cited by 92
Zheng, Z., Yang, X. H., Zhang, Y., Zu, W., Wen, M., Liu, T., Zhou, C., & Li, L. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120493 · Cited by 91
Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression
Fierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2009) · Diabetes · doi:10.2337/db09-1291 · Cited by 92
mRNA Translation and Energy Metabolism in Cancer: The Role of the MAPK and mTORC1 PathwaysPreprint
Topisirović, I., & Sonenberg, N. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010785 · Cited by 96
Self-citationMetformin: New Preparations and Nonglycemic Benefits
Fujita, Y., & Inagaki, N. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0829-8 · Cited by 91
Hulea, L., Gravel, S., Morita, M., Cargnello, M., Uchenunu, O., Im, Y. K., Lehuédé, C., Ma, E. H., Leibovitch, M., McLaughlan, S., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.001 · Cited by 91
Self-citationVarayathu, H., Sarathy, V., Thomas, B. E., Mufti, S. S., & Naik, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.559161 · Cited by 96
Type 2 Diabetes and Cancer: What Is the Connection?
Cannata, D., Fierz, Y., Vijayakumar, A., & LeRoith, D. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20167 · Cited by 94
Gardini, A. C., Faloppi, L., Matteis, S. D., Foschi, F. G., Silvestris, N., Tovoli, F., Palmieri, V. O., Marisi, G., Brunetti, O., Gentilucci, U. V., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.09.003 · Cited by 89
New drugs are not enough‑drug repositioning in oncology: An update
Armando, R., Mengual G�mez, D., & Gomez, D. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4966 · Cited by 90
The acetyl-CoA carboxylase enzyme: a target for cancer therapy?
Wang, C., Ma, J., Zhang, N., Yang, Q., Jin, Y., & Wang, Y. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1038246 · Cited by 87
Bost, F., Sahra, I. B., MARCHAND‐BRUSTEL, Y. L., & Tanti, J. (2011) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834d8155 · Cited by 95
Yu, C., Jiao, Y., Xue, J., Zhang, Q., Yang, H., Xing, L., Chen, G., Wu, J., Zhang, S., Zhu, W., et al. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.18830 · Cited by 88
Metformin as Potential Therapy for High-Grade Glioma
Mazurek, M., Litak, J., Kamieniak, P., Kulesza, B., Jonak, K. E., Baj, J., & Grochowski, C. (2020) · Cancers · doi:10.3390/cancers12010210 · Cited by 90
Olatunde, A., Nigam, M., SINGH, R. K., Panwar, A. S., Lasisi, A., Alhumaydhi, F. A., Kumar, V., Mishra, A. P., & Sharifi‐Rad, J. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02202-5 · Cited by 94
Jin, Q., Feng, L., Behrens, C., Bekele, B. N., Wistuba, I. I., Hong, W.-K., & Lee, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2401 · Cited by 86
Afzal, M. Z., Dragnev, K. H., Sarwar, T., & Shirai, K. (2019) · Lung Cancer Management · doi:10.2217/lmt-2018-0016 · Cited by 90
Uzbekova, S., Arlot‐Bonnemains, Y., Dupont, J., Dalbiès‐Tran, R., Papillier, P., Pennetier, S., Thélie, A., Perreau, C., Mermillod, P., Prigent, C., et al. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.107.061036 · Cited by 90
Clinical Outcomes After Radical Prostatectomy in Diabetic Patients Treated With Metformin
Patel, T., Hruby, G. W., Badani, K. K., Abate-Shen, C. T., & McKiernan, J. M. (2010) · Urology · doi:10.1016/j.urology.2010.03.059 · Cited by 85
Luo, Q., Hu, D., Hu, S., Yan, M., Sun, Z., & Chen, F. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-517 · Cited by 87
Changing the energy of an immune response.
Delmastro-Greenwood, M. M., & Piganelli, J. D. (2013) · Europe PMC (PubMed Central) · Cited by 84
Zhang, T., Guo, P., Zhang, Y., Xiong, H., Yu, X., Xu, S., Wang, X., He, D., & Jin, X. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141224603 · Cited by 84
Syrosingopine sensitizes cancer cells to killing by metformin
Benjamin, D., Colombi, M., Hindupur, S. K., Betz, C., Lane, H. A., El‐Shemerly, M., Lu, M., Quagliata, L., Terracciano, L., Moes, S., et al. (2016) · Science Advances · doi:10.1126/sciadv.1601756 · Cited by 89
Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
Ricci, J., & Chiche, J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00556 · Cited by 87
Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review
Ahn, H. K., Lee, Y. H., & Koo, K. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228540 · Cited by 87
Biguanides: Species with versatile therapeutic applications
Kathuria, D., Raul, A. D., Wanjari, P. J., & Bharatam, P. V. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113378 · Cited by 87
Tosca, L., Ramé, C., Chabrolle, C., Tesseraud, S., & Dupont, J. (2009) · Reproduction · doi:10.1530/rep-09-0351 · Cited by 86
Bao, B., Azmi, A. S., Ali, S. S., Zaiem, F., & Sarkar, F. H. (2014) · PubMed Central · doi:10.3978/j.issn.2305-5839.2014.06.05 · Cited by 85
Lee, H., Park, H. J., Park, C., Oh, E., Choi, B.-H., Williams, B. W., Lee, C. K. K., & Song, C. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087979 · Cited by 84
RetractedEffects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
Zhang, Y., Guan, M., Zheng, Z., Zhang, Q., Gao, F., & Xue, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081264 · Cited by 85
Metformin inhibits the development and metastasis of ovarian cancer
Wu, B., Li, S., SHENG, L., Zhu, J., Gu, L., SHEN, H., Duan-duan, L., Hambly, B. D., Bao, S., & Di, W. J. (2012) · Oncology Reports · doi:10.3892/or.2012.1890 · Cited by 86
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer
Tebbe, C., Chhina, J., Dar, S. A., Sarigiannis, K. A., Giri, S., Munkarah, A. R., & Rattan, R. (2014) · Oncotarget · doi:10.18632/oncotarget.2012 · Cited by 83
The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth
Feng, Y., Velázquez-Torres, G., Gully, C., Chen, J., Lee, M., & Yeung, S. J. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01083.x · Cited by 85
Joung, K. H., Jeong, J., & Ku, B. J. (2015) · BioMed Research International · doi:10.1155/2015/920618 · Cited by 86
Measuring the biological effect of presurgical metformin treatment in endometrial cancer
Sivalingam, V. N., Kitson, S., McVey, R. J., Roberts, C., Pemberton, P. W., Gilmour, K., Ali, S., Renehan, A. G., Kitchener, H. C., & Crosbie, E. J. (2016) · British Journal of Cancer · doi:10.1038/bjc.2015.453 · Cited by 82
Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning
Gadducci, A., Biglia, N., Tana, R., Cosio, S., & Gallo, M. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.06.006 · Cited by 87
Zhang, J., Shen, C., Wang, L., Ma, Q., Xia, P., Qi, M., Yang, M., & Han, B. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.154 · Cited by 83
The effect of metformin on apoptosis in a breast cancer presurgical trial
Cazzaniga, M. E., DeCensi, A., Pruneri, G., Puntoni, M., Bottiglieri, L., Varricchio, C., Guerrieri‐Gonzaga, A., Gentilini, O., Pagani, G., Dell’Orto, P., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.657 · Cited by 81
Nutrition, metabolic factors and cancer risk
Dossus, L., & Kaaks, R. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.08.003 · Cited by 82
Metformin in prostate cancer: two for the price of one
Clements, A., Gao, B., Yeap, S. H., Wong, M. K., Ali, S. S., & Gurney, H. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr037 · Cited by 80
Chaube, B., Malvi, P., Singh, S. V., Mohammad, N., Meena, A. S., & Bhat, M. K. (2015) · Oncotarget · doi:10.18632/oncotarget.6134 · Cited by 80
Metadata
- Authors
- Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M.
- Affiliations
- 1Oncology and Departments of
- McGill University (CA)
- Mount Sinai Hospital (CA)
- Venue
- Cancer Research
- Published
- 2006-11-01
- Volume
- 66
- Issue
- 21
- Pages
- 10269-10273
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2078190084
- Cited by
- 1,048
- References
- 20
- Citations by year
- 2026: 13 · 2025: 11 · 2024: 24 · 2023: 29 · 2022: 28 · 2021: 54 · 2020: 47 · 2019: 62 · 2018: 55 · 2017: 70 · 2016: 70 · 2015: 80 · 2014: 93 · 2013: 86 · 2012: 85
- FWCI
- 12.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- Funders
- Canadian Breast Cancer Research Alliance
- Terry Fox Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- metformin, AMP kinase, breast cancer, cell growth inhibition, antineoplastic effects, mTOR, S6 kinase, mRNA translation, insulin resistance, insulin-like growth factor, epithelial cells, cancer prevention
- MeSH terms
- Adenylate Kinase, Antineoplastic Agents, Breast Neoplasms, Female, Humans, Insulin, Metformin, Protein Biosynthesis, Gene Expression Regulation, Enzymologic, RNA, Small Interfering, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
